Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Sheena K. Aurora | Researchclopedia

Back to researchers

Sheena K. Aurora

C2N Diagnostics (United States)ORCID

160

Works

9,392

Citations

43

h-index

78

i10-index

Research Topics

Migraine and Headache Studies Trigeminal Neuralgia and Treatments Sympathectomy and Hyperhidrosis Treatments

Affiliations

University of Iowa2007–2007

University of Maryland, Baltimore2019–2019

Merck & Co., Inc., Rahway, NJ, USA (United States)2010–2012

Ford Motor Company (United States)2001–2001

Albert Einstein College of Medicine2010–2019

Top Works

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

David W. Dodick,Catherine C. Turkel,et al.

2010970 citations

Ophthalmology and Eye Disorders

Olfactory and Sensory Function Studies

Periaqueductal Gray Matter Dysfunction in Migraine: Cause or the Burden of Illness?

K.M.A. Welch,Vijaya Nagesh,et al.

2001619 citations

Galcanezumab in chronic migraine

Holland C. Detke,Peter J. Goadsby,et al.

2018568 citations

CGRP and the Trigeminal System in Migraine

Smriti Iyengar,Kirk W. Johnson,et al.

2019473 citations

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

Richard B. Lipton,David W. Dodick,et al.

2010458 citations

Functional MRI-BOLD of Visually Triggered Headache in Patients With Migraine

Yue Cao,K.M.A. Welch,et al.

1999344 citations

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program

Sheena K. Aurora,Paul Winner,et al.

2011296 citations

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Wim M. Mulleners,Byung‐Kun Kim,et al.

2020275 citations

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine

Peter J. Goadsby,Linda Wietecha,et al.

2019271 citations